Issuer · CIK 0001720893
BTAI — BioXcel Therapeutics, Inc.
Recent filings
- Jun 18, 2026·Form 4·Other—
BTAI/BioXcel Therapeutics, Inc.
Rodriguez Javier · See Remarks
Mechanical filing
AI thesis skipped - Jun 18, 2026·Form 4·Other—
BTAI/BioXcel Therapeutics, Inc.
Steinhart Richard I · Chief Financial Officer
Mechanical filing
AI thesis skipped - Jun 18, 2026·Form 4·Other—
BTAI/BioXcel Therapeutics, Inc.
Yocca Frank · Chief Scientific Officer
Mechanical filing
AI thesis skipped - Jun 18, 2026·Form 4·Other—
BTAI/BioXcel Therapeutics, Inc.
Mehta Vimal · CEO and President
Mechanical filing
AI thesis skipped - May 22, 2026·Form 4·Sell$7.4K
BTAI/BioXcel Therapeutics, Inc.
Yocca Frank · Chief Scientific Officer
28conviction - May 22, 2026·Form 4·Sell$7.1K
BTAI/BioXcel Therapeutics, Inc.
Rodriguez Javier · See Remarks
22conviction - May 22, 2026·Form 4·Sell$7.4K
BTAI/BioXcel Therapeutics, Inc.
Steinhart Richard I · Chief Financial Officer
32conviction - May 22, 2026·Form 4·Sell$21.1K
BTAI/BioXcel Therapeutics, Inc.
Mehta Vimal · CEO and President
32conviction - May 7, 2026·Form 4·Other—
BTAI/BioXcel Therapeutics, Inc.
Mehta Vimal · CEO and President
Mechanical filing
AI thesis skipped - May 7, 2026·Form 4·Other—
BTAI/BioXcel Therapeutics, Inc.
Steinhart Richard I · Chief Financial Officer
Mechanical filing
AI thesis skipped - May 7, 2026·Form 4·Other—
BTAI/BioXcel Therapeutics, Inc.
Yocca Frank · Chief Scientific Officer
Mechanical filing
AI thesis skipped - May 7, 2026·Form 4·Other—
BTAI/BioXcel Therapeutics, Inc.
Rodriguez Javier · See Remarks
Mechanical filing
AI thesis skipped